Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Aug;49(2):251–262. doi: 10.1136/gut.49.2.251

Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis

K Detjen 1, K Farwig 1, M Welzel 1, B Wiedenmann 1, S Rosewicz 1
PMCID: PMC1728385  PMID: 11454803

Abstract

BACKGROUND AND AIMS—The poor prognosis of pancreatic cancer is partly due to resistance to a broad spectrum of apoptotic stimuli. To identify intact proapoptotic pathways of potential clinical relevance, we characterised the effects of interferon γ (IFN-γ) on growth and survival in human pancreatic cancer cells.
METHODS—IFN-γ receptor expression and signal transduction were examined by reverse transcriptase-polymerase chain reaction (RT-PCR), immunoprecipitation, western blot analysis, and transactivation assays. Effects on cell growth and survival were evaluated in terms of cell numbers, colony formation, cell cycle analysis, DNA fragmentation, and poly(ADP ribose) polymerase (PARP) cleavage.
RESULTS—All four pancreatic cancer cell lines examined expressed functional IFN-γ receptors and downstream effectors, including the putative tumour suppressor interferon regulatory factor 1 (IRF-1). IFN-γ treatment profoundly inhibited anchorage dependent and independent growth of pancreatic cancer cells. Cell cycle analyses revealed subdiploid cells suggesting apoptosis, which was confirmed by demonstration of DNA fragmentation and PARP cleavage. Time and dose dependency of apoptosis induction and growth inhibition correlated closely, identifying apoptosis as the main, if not exclusive, mechanism responsible for growth inhibition. Apoptosis was preceded by upregulation of procaspase-1 and accompanied by proteolytic activation. Furthermore, the caspase inhibitor z-vad-fmk completely prevented IFN-γ mediated apoptosis.
CONCLUSIONS—These results identify an intact proapoptotic pathway in pancreatic cancer cells and suggest that IRF-1 and/or procaspase-1 may represent potential therapeutic targets to be further explored.


Keywords: interferon γ; apoptosis; caspase-1;interferon regulatory factor; pancreatic cancer

Full Text

The Full Text of this article is available as a PDF (288.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Pancreatic cancer cells express interferon γ receptor (IFN-γ-R) mRNA transcripts. Total mRNA was extracted, reverse transcribed into cDNA, and amplified using polymerase chain reaction with specific primers directed against the IFN-γ-R α chain. Alternating lanes represent reaction with (+) or without (−) addition of reverse transcriptase (RT). The expected size of the amplification product was 559 bp and a 100 bp DNA standard was included for size determination (lane 1).

Figure 2  .

Figure 2  

Open in a new tab

Interferon γ (IFN-γ) activates the Jak-Stat signal transduction pathway in human pancreatic cancer cells. Cells were stimulated with 500 IU/ml IFN-γ for the indicated time periods and Jak-1 (A), Jak-2 (B), and Stat-1 (C) were immunoprecipitated (IP) from cell lysates. Immunoblots were performed to determine IFN-γ induced changes in the phosphotyrosine content of Jak and Stat complexes (top panels). To ensure that equal amounts of protein had been examined, the western blots (WB) were subsequently stripped and reprobed with Jak-1, Jak-2, or Stat-1 antibody, respectively (bottom panels). Molecular masses were deduced from a molecular size marker electrophoresed in parallel.

Figure 3  .

Figure 3  

Open in a new tab

Interferon γ (IFN-γ) stimulation results in transactivation of a GAS driven reporter construct. AsPc-1 cells were transiently transfected with pGL2-GAS and relative luciferase activity was measured after a 24 hour period of IFN-γ stimulation with the indicated doses. Data represent mean (SEM) values from at least three separate experiments conducted in triplicate.

Figure 4  .

Figure 4  

Open in a new tab

Interferon γ (IFN-γ) inhibits anchorage dependent and independent growth of human pancreatic cancer cells. Subconfluent cells were treated with 500 IU/ml IFN-γ or vehicle for the indicated time periods (A), or with the indicated final concentrations of IFN-γ for 96 hours (B) and cell numbers were determined. (C) A single cell agar suspension containing 1×103 cells was incubated with the indicated doses of IFN-γ for 10 days and colony formation was evaluated. Data represent mean (SEM) values from at least three separate experiments, each conducted in triplicate (*p<0.01).

Figure 5  .

Figure 5  

Open in a new tab

Interferon γ (IFN-γ) treated pancreatic tumour cells contain a subdiploid DNA complement. (A) Time course of representative FACS analyses illustrating the cell cycle distribution of pancreatic cancer cells under control conditions (top panel) or in the presence of 500 IU/ml IFN-γ (bottom panel). (B) Summary of IFN-γ induced cell cycle redistribution. Mean (SEM) percentage of cells with subdiploid DNA content were determined in three independent experiments. *p<0.01 versus time matched untreated controls. (C) Alignment of growth inhibition and apoptosis.

Figure 6  .

Figure 6  

Open in a new tab

Interferon γ (IFN-γ) induced DNA fragmentation and poly(ADP ribose) polymerase (PARP) cleavage in human pancreatic cancer cell lines. (A) Cells were incubated for four days with 500 IU/ml IFN-γ (lanes 3, 5, 7, and 9) or left untreated (lanes 2, 4, 6, and 8) and genomic DNA was subsequently analysed for oligonucleosomal fragmentation. For size determination a 100 bp DNA standard was used (lane 1). (B) Cells were treated with vehicle or IFN-γ (500 IU/ml) for the indicated time periods and examined using a specific histone DNA ELISA to quantitate DNA fragmentation. Mean (SEM) absorbance at 405 nm relative to untreated controls was determined in three independent experiments, each performed in triplicate. (C) Immunoblot demonstrating expression of PARP (p 116) and its apoptosis related cleavage product p 85 in untreated controls and cells that had been treated with 500 IU/ml IFN-γ for the time periods indicated. Alternating lanes represent IFN-γ treated (+) and untreated (−) cells. Whole cell lysates were separated by 7.5% sodium dodecyl sulphate-polyacrylamide gel electrophoresis.

Figure 7  .

Figure 7  

Open in a new tab

Interferon γ (IFN-γ) treatment regulates retinoblastoma protein (pRb) phosphorylation and abundance in human pancreatic cancer cells. Immunoblot analysis demonstrating the time course of changes in pRb expression and phosphorylation status in control and IFN-γ stimulated human pancreatic cancer cells. In each lane, 20 µg of whole cell lysates were separated by 7.5% sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Shown is a representative of two experiments yielding similar results. pRb, ppRb, hypo- and hyperphosphorylated forms of Retinoblastoma protein, respectively.

Figure 8  .

Figure 8  

Open in a new tab

Interferon γ (IFN-γ) mediated apoptosis is prevented by the caspase inhibitor z-vad-fmk. Cells were stimulated for three days with either IFN-γ (500 IU/ml), a combination of IFN-γ and z-vad-fmk at various doses, or were left untreated. Subsequently, cells were analysed by flow cytometry and the fraction of cells with subdiploid DNA content was quantitated. Mean (SEM) percentage of cells with subdiploid DNA content was determined in three independent experiments.

Figure 9  .

Figure 9  

Open in a new tab

Interferon γ (IFN-γ) causes upregulation of procaspase-1 and interferon regulatory factor 1 (IRF-1) in pancreatic cancer cell lines. (A) Cells were incubated with vehicle or IFN-γ (500 IU/ml) for the indicated time periods. Aliquots of 20 µg of whole cell lysate were separated by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS PAGE) and subsequently incubated with an anticaspase antibody that recognises a double band of the procaspase precursor form at approximately 45 kDa. (B) Immunoblot revealing caspase-1 processing intermediates with the 35 kDa form indicative of activation. Lysates were from AsPc-1 and Dan-G cells treated for 48 and 72 hours with 500 IU/ml IFN-γ or time matched control cells. In Dan-G cells, top and bottom panels represent light and darker exposures of the same blot. (C) Immunoblot analysis for IRF-1 expression. Cells were incubated with vehicle or IFN-γ (500 IU/ml) for the indicated time periods. In each lane, 20 µg of whole cell lysates were separated by 12% SDS-PAGE and IRF-1 expression was determined using a monospecific antibody. Shown are representative blots of at least two experiments.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An B., Dou Q. P. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res. 1996 Feb 1;56(3):438–442. [PubMed] [Google Scholar]
  2. Arany I., Brysk M. M., Calhoun K. H., Tyring S. K. Differentiation and IFN gamma regulate WAF1/CIP1 transcription in p53-independent and p53-dependent pathways in epithelial cells. In Vivo. 1996 Jan-Feb;10(1):119–123. [PubMed] [Google Scholar]
  3. Arenberg D. A., Kunkel S. L., Polverini P. J., Morris S. B., Burdick M. D., Glass M. C., Taub D. T., Iannettoni M. D., Whyte R. I., Strieter R. M. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med. 1996 Sep 1;184(3):981–992. doi: 10.1084/jem.184.3.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bach E. A., Aguet M., Schreiber R. D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997;15:563–591. doi: 10.1146/annurev.immunol.15.1.563. [DOI] [PubMed] [Google Scholar]
  5. Balachandran S., Kim C. N., Yeh W. C., Mak T. W., Bhalla K., Barber G. N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 1998 Dec 1;17(23):6888–6902. doi: 10.1093/emboj/17.23.6888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Berry D. E., Lu Y., Schmidt B., Fallon P. G., O'Connell C., Hu S. X., Xu H. J., Blanck G. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene. 1996 Apr 18;12(8):1809–1819. [PubMed] [Google Scholar]
  7. Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795. doi: 10.1146/annurev.immunol.15.1.749. [DOI] [PubMed] [Google Scholar]
  8. Bramhall S. R., Allum W. H., Jones A. G., Allwood A., Cummins C., Neoptolemos J. P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995 Jan;82(1):111–115. doi: 10.1002/bjs.1800820137. [DOI] [PubMed] [Google Scholar]
  9. Bromberg J. F., Horvath C. M., Wen Z., Schreiber R. D., Darnell J. E., Jr Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7673–7678. doi: 10.1073/pnas.93.15.7673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brysk M. M., Selvanayagam P., Arany I., Brysk H., Tyring S. K., Rajaraman S. Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J Interferon Cytokine Res. 1995 Dec;15(12):1029–1035. doi: 10.1089/jir.1995.15.1029. [DOI] [PubMed] [Google Scholar]
  11. Buard A., Vivo C., Monnet I., Boutin C., Pilatte Y., Jaurand M. C. Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma. Cancer Res. 1998 Feb 15;58(4):840–847. [PubMed] [Google Scholar]
  12. Burke F., Smith P. D., Crompton M. R., Upton C., Balkwill F. R. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA. Br J Cancer. 1999 Jun;80(8):1236–1244. doi: 10.1038/sj.bjc.6690491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chin Y. E., Kitagawa M., Kuida K., Flavell R. A., Fu X. Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol. 1997 Sep;17(9):5328–5337. doi: 10.1128/mcb.17.9.5328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chin Y. E., Kitagawa M., Su W. C., You Z. H., Iwamoto Y., Fu X. Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science. 1996 May 3;272(5262):719–722. doi: 10.1126/science.272.5262.719. [DOI] [PubMed] [Google Scholar]
  15. Cohen G. M. Caspases: the executioners of apoptosis. Biochem J. 1997 Aug 15;326(Pt 1):1–16. doi: 10.1042/bj3260001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Decker T., Kovarik P., Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res. 1997 Mar;17(3):121–134. doi: 10.1089/jir.1997.17.121. [DOI] [PubMed] [Google Scholar]
  17. Delvenne P., al-Saleh W., Gilles C., Thiry A., Boniver J. Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha. Am J Pathol. 1995 Mar;146(3):589–598. [PMC free article] [PubMed] [Google Scholar]
  18. Der S. D., Yang Y. L., Weissmann C., Williams B. R. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3279–3283. doi: 10.1073/pnas.94.7.3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dighe A. S., Richards E., Old L. J., Schreiber R. D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1994 Sep;1(6):447–456. doi: 10.1016/1074-7613(94)90087-6. [DOI] [PubMed] [Google Scholar]
  20. Dou Q. P., An B. RB and apoptotic cell death. Front Biosci. 1998 Apr 6;3:d419–d430. doi: 10.2741/a288. [DOI] [PubMed] [Google Scholar]
  21. Drexler H. G., Zaborski M., Quentmeier H. Interferon-gamma induced proliferation of human myeloid leukaemia cell lines. Br J Haematol. 1997 Sep;98(3):699–710. doi: 10.1046/j.1365-2141.1997.2673084.x. [DOI] [PubMed] [Google Scholar]
  22. Foon K. A., Sherwin S. A., Abrams P. G., Stevenson H. C., Holmes P., Maluish A. E., Oldham R. K., Herberman R. B. A phase I trial of recombinant gamma interferon in patients with cancer. Cancer Immunol Immunother. 1985;20(3):193–197. doi: 10.1007/BF00205575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gansauge F., Gansauge S., Schmidt E., Müller J., Beger H. G. Prognostic significance of molecular alterations in human pancreatic carcinoma--an immunohistological study. Langenbecks Arch Surg. 1998 Apr;383(2):152–155. doi: 10.1007/pl00008076. [DOI] [PubMed] [Google Scholar]
  24. Green D. R. Apoptotic pathways: the roads to ruin. Cell. 1998 Sep 18;94(6):695–698. doi: 10.1016/s0092-8674(00)81728-6. [DOI] [PubMed] [Google Scholar]
  25. Harvat B. L., Jetten A. M. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ. 1996 Mar;7(3):289–300. [PubMed] [Google Scholar]
  26. Harvat B. L., Seth P., Jetten A. M. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene. 1997 May 1;14(17):2111–2122. doi: 10.1038/sj.onc.1201055. [DOI] [PubMed] [Google Scholar]
  27. Hobeika A. C., Etienne W., Cruz P. E., Subramaniam P. S., Johnson H. M. IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential. Int J Cancer. 1998 Jul 3;77(1):138–145. doi: 10.1002/(sici)1097-0215(19980703)77:1<138::aid-ijc21>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  28. Horiuchi M., Yamada H., Akishita M., Ito M., Tamura K., Dzau V. J. Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells. Hypertension. 1999 Jan;33(1):162–166. doi: 10.1161/01.hyp.33.1.162. [DOI] [PubMed] [Google Scholar]
  29. Hu Y. X., Watanabe H., Ohtsubo K., Yamaguchi Y., Ha A., Motoo Y., Okai T., Sawabu N. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma. Br J Cancer. 1999 Jun;80(7):1075–1079. doi: 10.1038/sj.bjc.6690466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Iwase S., Furukawa Y., Kikuchi J., Saito S., Nakamura M., Nakayama R., Horiguchi-Yamada J., Yamada H. Defective binding of IRFs to the initiator element of interleukin-1beta-converting enzyme (ICE) promoter in an interferon-resistant Daudi subline. FEBS Lett. 1999 May 7;450(3):263–267. doi: 10.1016/s0014-5793(99)00515-3. [DOI] [PubMed] [Google Scholar]
  31. Jia S. F., Kleinerman E. S. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines. Lymphokine Cytokine Res. 1991 Aug;10(4):281–284. [PubMed] [Google Scholar]
  32. Jänicke R. U., Walker P. A., Lin X. Y., Porter A. G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 1996 Dec 16;15(24):6969–6978. [PMC free article] [PubMed] [Google Scholar]
  33. Kano A., Watanabe Y., Takeda N., Aizawa S., Akaike T. Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. J Biochem. 1997 Apr;121(4):677–683. doi: 10.1093/oxfordjournals.jbchem.a021639. [DOI] [PubMed] [Google Scholar]
  34. Kanzaki M., Morris P. L. Identification and regulation of testicular interferon-gamma (IFNgamma) receptor subunits: IFNgamma enhances interferon regulatory factor-1 and interleukin-1beta converting enzyme expression. Endocrinology. 1998 May;139(5):2636–2644. doi: 10.1210/endo.139.5.5975. [DOI] [PubMed] [Google Scholar]
  35. Kaplan D. H., Shankaran V., Dighe A. S., Stockert E., Aguet M., Old L. J., Schreiber R. D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556–7561. doi: 10.1073/pnas.95.13.7556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993 Sep 1;53(17):3976–3985. [PubMed] [Google Scholar]
  37. Kominsky S., Johnson H. M., Bryan G., Tanabe T., Hobeika A. C., Subramaniam P. S., Torres B. IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1. Oncogene. 1998 Dec 10;17(23):2973–2979. doi: 10.1038/sj.onc.1202217. [DOI] [PubMed] [Google Scholar]
  38. Lee S. B., Rodríguez D., Rodríguez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 1997 Apr 28;231(1):81–88. doi: 10.1006/viro.1997.8494. [DOI] [PubMed] [Google Scholar]
  39. Maier J. A., Morelli D., Balsari A. The differential response to interferon gamma by normal and transformed endothelial cells. Biochem Biophys Res Commun. 1995 Sep 14;214(2):582–588. doi: 10.1006/bbrc.1995.2325. [DOI] [PubMed] [Google Scholar]
  40. Matsuoka M., Nishimoto I., Asano S. Interferon-gamma impairs physiologic downregulation of cyclin-dependent kinase inhibitor, p27Kip1, during G1 phase progression in macrophages. Exp Hematol. 1999 Feb;27(2):203–209. doi: 10.1016/s0301-472x(98)00034-4. [DOI] [PubMed] [Google Scholar]
  41. Miura M., Zhu H., Rotello R., Hartwieg E. A., Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993 Nov 19;75(4):653–660. doi: 10.1016/0092-8674(93)90486-a. [DOI] [PubMed] [Google Scholar]
  42. Mäkinen K., Hakala T., Lipponen P., Alhava E., Eskelinen M. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Anticancer Res. 1998 Jan-Feb;18(1B):615–618. [PubMed] [Google Scholar]
  43. Nagata S. Apoptosis by death factor. Cell. 1997 Feb 7;88(3):355–365. doi: 10.1016/s0092-8674(00)81874-7. [DOI] [PubMed] [Google Scholar]
  44. Nagata S. Fas-induced apoptosis. Intern Med. 1998 Feb;37(2):179–181. doi: 10.2169/internalmedicine.37.179. [DOI] [PubMed] [Google Scholar]
  45. Palumbo A., Battaglio S., Napoli P., Omedè P., Fusaro A., Bruno B., Boccadoro M., Pileri A. Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells. Br J Haematol. 1994 Apr;86(4):726–732. doi: 10.1111/j.1365-2141.1994.tb04821.x. [DOI] [PubMed] [Google Scholar]
  46. Perugini R. A., McDade T. P., Vittimberga F. J., Jr, Callery M. P. The molecular and cellular biology of pancreatic cancer. Crit Rev Eukaryot Gene Expr. 1998;8(3-4):377–393. doi: 10.1615/critreveukargeneexpr.v8.i3-4.70. [DOI] [PubMed] [Google Scholar]
  47. Phan-Bich L., Buard A., Petit J. F., Zeng L., Tenu J. P., Chretien P., Monnet I., Boutin C., Bignon J., Lemaire G. Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gamma. Am J Respir Cell Mol Biol. 1997 Feb;16(2):178–186. doi: 10.1165/ajrcmb.16.2.9032125. [DOI] [PubMed] [Google Scholar]
  48. Platanias L. C., Fish E. N. Signaling pathways activated by interferons. Exp Hematol. 1999 Nov;27(11):1583–1592. doi: 10.1016/s0301-472x(99)00109-5. [DOI] [PubMed] [Google Scholar]
  49. Raff M. Cell suicide for beginners. Nature. 1998 Nov 12;396(6707):119–122. doi: 10.1038/24055. [DOI] [PubMed] [Google Scholar]
  50. Raveh T., Hovanessian A. G., Meurs E. F., Sonenberg N., Kimchi A. Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons. J Biol Chem. 1996 Oct 11;271(41):25479–25484. doi: 10.1074/jbc.271.41.25479. [DOI] [PubMed] [Google Scholar]
  51. Rodig S., Kaplan D., Shankaran V., Old L., Schreiber R. D. Signaling and signaling dysfunction through the interferon gamma receptor. Eur Cytokine Netw. 1998 Sep;9(3 Suppl):49–53. [PubMed] [Google Scholar]
  52. Rosewicz S., Stier U., Brembeck F., Kaiser A., Papadimitriou C. A., Berdel W. E., Wiedenmann B., Riecken E. O. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology. 1995 Nov;109(5):1646–1660. doi: 10.1016/0016-5085(95)90655-x. [DOI] [PubMed] [Google Scholar]
  53. Rosewicz S., Weder M., Kaiser A., Riecken E. O. Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes. Gut. 1996 Aug;39(2):255–261. doi: 10.1136/gut.39.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rosewicz S., Wiedenmann B. Pancreatic carcinoma. Lancet. 1997 Feb 15;349(9050):485–489. doi: 10.1016/s0140-6736(96)05523-7. [DOI] [PubMed] [Google Scholar]
  55. Rozenblum E., Schutte M., Goggins M., Hahn S. A., Panzer S., Zahurak M., Goodman S. N., Sohn T. A., Hruban R. H., Yeo C. J. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997 May 1;57(9):1731–1734. [PubMed] [Google Scholar]
  56. Rubin B. Y., Gupta S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928–5932. doi: 10.1073/pnas.77.10.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Ruemmele F. M., Gurbindo C., Mansour A. M., Marchand R., Levy E., Seidman E. G. Effects of interferon gamma on growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (IEC-6) cells. J Cell Physiol. 1998 Jul;176(1):120–126. doi: 10.1002/(SICI)1097-4652(199807)176:1<120::AID-JCP14>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  58. Sato T., Selleri C., Young N. S., Maciejewski J. P. Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood. 1995 Nov 1;86(9):3373–3380. [PubMed] [Google Scholar]
  59. Sato T., Selleri C., Young N. S., Maciejewski J. P. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood. 1997 Dec 15;90(12):4749–4758. [PubMed] [Google Scholar]
  60. Simbulan-Rosenthal C. M., Rosenthal D. S., Iyer S., Boulares H., Smulson M. E. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol Cell Biochem. 1999 Mar;193(1-2):137–148. [PubMed] [Google Scholar]
  61. Subramaniam P. S., Johnson H. M. A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons. J Interferon Cytokine Res. 1997 Jan;17(1):11–15. doi: 10.1089/jir.1997.17.11. [DOI] [PubMed] [Google Scholar]
  62. Tada S., Saito H., Tsunematsu S., Ebinuma H., Wakabayashi K., Masuda T., Ishii H. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines. Int J Oncol. 1998 Dec;13(6):1207–1216. doi: 10.3892/ijo.13.6.1207. [DOI] [PubMed] [Google Scholar]
  63. Tamura T., Ishihara M., Lamphier M. S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T. W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 1995 Aug 17;376(6541):596–599. doi: 10.1038/376596a0. [DOI] [PubMed] [Google Scholar]
  64. Tamura T., Ishihara M., Lamphier M. S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T. W., Taki S., Taniguchi T. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia. 1997 Apr;11 (Suppl 3):439–440. [PubMed] [Google Scholar]
  65. Tamura T., Ueda S., Yoshida M., Matsuzaki M., Mohri H., Okubo T. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun. 1996 Dec 4;229(1):21–26. doi: 10.1006/bbrc.1996.1752. [DOI] [PubMed] [Google Scholar]
  66. Tan X., Wang J. Y. The caspase-RB connection in cell death. Trends Cell Biol. 1998 Mar;8(3):116–120. doi: 10.1016/s0962-8924(97)01208-7. [DOI] [PubMed] [Google Scholar]
  67. Taniguchi T., Lamphier M. S., Tanaka N. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim Biophys Acta. 1997 Aug 8;1333(1):M9–17. doi: 10.1016/s0304-419x(97)00014-0. [DOI] [PubMed] [Google Scholar]
  68. Ungefroren H., Voss M., Jansen M., Roeder C., Henne-Bruns D., Kremer B., Kalthoff H. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 1998 Apr 15;58(8):1741–1749. [PubMed] [Google Scholar]
  69. Vadiveloo P. K., Vairo G., Novak U., Royston A. K., Whitty G., Filonzi E. L., Cragoe E. J., Jr, Hamilton J. A. Differential regulation of cell cycle machinery by various antiproliferative agents is linked to macrophage arrest at distinct G1 checkpoints. Oncogene. 1996 Aug 1;13(3):599–608. [PubMed] [Google Scholar]
  70. Vairo G., Vadiveloo P. K., Royston A. K., Rockman S. P., Rock C. O., Jackowski S., Hamilton J. A. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest. Oncogene. 1995 May 18;10(10):1969–1976. [PubMed] [Google Scholar]
  71. Wada M., Hosotani R., Lee J. U., Doi R., Koshiba T., Fujimoto K., Miyamoto Y., Tsuji S., Nakajima S., Okuyama A. An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. Anticancer Res. 1998 Jul-Aug;18(4A):2559–2566. [PubMed] [Google Scholar]
  72. Watanabe Y., Kuribayashi K., Miyatake S., Nishihara K., Nakayama E., Taniyama T., Sakata T. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9456–9460. doi: 10.1073/pnas.86.23.9456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Wolf B. B., Green D. R. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem. 1999 Jul 16;274(29):20049–20052. doi: 10.1074/jbc.274.29.20049. [DOI] [PubMed] [Google Scholar]
  74. Wolf B. B., Schuler M., Echeverri F., Green D. R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem. 1999 Oct 22;274(43):30651–30656. doi: 10.1074/jbc.274.43.30651. [DOI] [PubMed] [Google Scholar]
  75. Xaus J., Cardó M., Valledor A. F., Soler C., Lloberas J., Celada A. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity. 1999 Jul;11(1):103–113. doi: 10.1016/s1074-7613(00)80085-0. [DOI] [PubMed] [Google Scholar]
  76. Yamin T. T., Ayala J. M., Miller D. K. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J Biol Chem. 1996 May 31;271(22):13273–13282. doi: 10.1074/jbc.271.22.13273. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES